Bio

Bio

After graduating from Brown Medical School, Dr. Lahijani completed the Combined Internal Medicine/Psychiatry Residency Program at Rush University Medical Center in Chicago. She then served as a physician in the areas of primary care and triple diagnosis (addiction, HIV, mental health). Dr. Lahijani thereafter completed the Psychosomatic Medicine Fellowship at the Feinberg School of Medicine of Northwestern University where she worked at the Lurie Comprehensive Cancer Center. During her fellowship, she also served as a psycho-oncologist at Memorial Sloan Kettering Cancer Center. Dr. Lahijani is trained in and administers different psychotherapeutic modalities, including Meaning Centered Psychotherapy and Dignity Therapy.

In 2015, Dr. Lahijani joined the faculty of Stanford University School of Medicine as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since her initial appointment, Dr. Lahijani has served as the lead psychiatric oncologist at the Stanford Cancer Center where she has provided psychiatric consultation services to patients with cancer and collaborated closely with her hematology and oncology colleagues to deliver comprehensive cancer care. In 2019, she was appointed as the Medical Director of the Stanford Cancer Center Psycho-Oncology Program. Dr. Lahijani also attends on the Consultation Liaison Psychiatry Service at Stanford Hospital and Clinics to provide care for patients with complex medical and psychiatric diagnoses and to teach psychiatry, internal medicine, and neurology trainees.

As Faculty of the Advancing Communication Excellence at Stanford, Dr. Lahijani leads foundational workshops for faculty and staff to advance communication skills with patients, families, and their colleagues. She is committed to developing and contributing to efforts that focus on relationship centered skills and provider wellness. Her clinical and scholarly interests include the interface of Medicine and Psychiatry, Psycho-Oncology, collaborative care models, psychotherapy for the medically ill, psychopharmacology, interdisciplinary medical education, teaching, and academic writing.

Clinical Focus

  • Internal Medicine
  • Psychiatry
  • Psychosomatic Medicine
  • Psycho-Oncology

Academic Appointments

  • Clinical Associate Professor, Psychiatry and Behavioral Sciences

Boards, Advisory Committees, Professional Organizations

  • Member, American College of Physicians (2007 - Present)
  • Member, Association of Medicine and Psychiatry (2009 - Present)
  • Member, Academy of Consultation Liaison Psychiatry (2014 - Present)
  • Member, American Psychosocial Oncology Society (2015 - Present)

Professional Education

  • Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2014)
  • Board Certification: Psychosomatic Medicine, American Board of Psychiatry and Neurology (2015)
  • Fellowship:Northwestern University Feinberg School of Medicine (2015) IL
  • Residency:Rush University Medical Center (2012)
  • Medical Education:Brown Medical School (2007) RI

Contact

  • Stanford Outpatient Psychiatry Clinic 401 Quarry Rd MC 5722 Stanford, CA 94305
    • Tel: (650) 498-9111
    Fax: (650) 724-3144

Teaching

Graduate and Fellowship Programs

Publications

All Publications

  • Medical Complications of Psychiatric Treatment An Update CRITICAL CARE CLINICS Lahijani, S. C., Harris, K. A. 2017; 33 (3): 713-+

    Abstract

    Psychiatric medications are used commonly in hospitalized patients and are particularly indicated in patients who are critically ill to manage many conditions. Due to their many indications in the intensive care unit (ICU), psychiatric medications should be closely monitored in these medically compromised patients for adverse reactions and medical complications because they may affect essentially all organ systems. These range from life-threatening reactions to other less significant effects, such as sedation, to other detrimental complications, such as pancreatitis. Knowledge of psychopharmacology as well as the diagnosis and treatment of these complications is imperative in treating patients in the ICU.

    View details for PubMedID 28601142

  • Managing Depression in Patients With Cancer ONCOLOGY-NEW YORK McFarland, D., Lahijani, S., Holland, J. 2016; 30 (7): 665?71

    View details for Web of Science ID 000381789400010

    View details for PubMedID 27422114

  • Insights from Collaborative Care: A Review of the Evidence for Depression and Diabetes Psychiatric Annals Lahijani, S., Rosenthal, L. 2015; 45 (8)
  • Neurosyphilis Presenting as Mania and Psychosis after Incidental Treatment with Cephalexin: a Case Report and Literature Review of Jarisch-Herxheimer Reactions Psychosomatics Spelber , D., Lahijani, S. 2019

    View details for DOI 10.1016/j.psym.2019.06.001

  • Supervision of Auxiliary Health Care Providers: Roles, Goals, and Learning Opportunities Supervision in Psychiatric Practice: Practical Approaches Across Venues and Providers Lahijani, S. edited by DeGolia, S., Corcoran, K. 2019: 375?382
  • Clinical Dilemmas in Evaluating and Treating Sleep Disorders in Cancer Journal of Psychosocial Oncology Research and Practice Lahijani, S. 2019; 1 (1S): e9
  • Somatic Complaints and Anxiety in Older Adults Practical Strategies in Geriatric Mental Health Cases and Approaches Lahijani, S. edited by Dunn, L., Cassidy-Eagle, E. American Psychiatric Association Publishing. 2019; 1
  • Cultural Aspects of Transplantation Psychosocial Care of End Organ Disease and Transplant Patients Lahijani, S., Garcia, R. edited by Sher, Y., Maldonado, J. 2018: 539?546
  • Neurosyphilis Presenting as Mania and Psychosis after Incidental Treatment with Cephalexin: A Case Report. Academy of Consultation Liaison Psychiatry Lahijani, S., Spelber, D., Maldonado, J. 2018
  • Buspirone for the Treatment of Severe Antipsychotic-Induced Extrapyramidal Symptoms Academy of Psychosomatic Medicine Lahijani, S., Rosenthal, L., Meltzer, H. 2015
  • Palliative and End-of-Life-Care of Borderline Personality Disorder in Older Adults Borderline personality disorder in older adults: Emphasis on care in institutional settings Leung, M., Lahijani, S., Mulligan, T. edited by Hategan, A., Bourgeois, J., Xiong, G. 2015: 123?128
  • Levofloxacin-Induced Fulminant Hepatic Failure American College of Physicians Lahijani, S., Kahn, E., Burke, G. 2008
  • Acute Hepatits B Presenting as Hepatitis American College of Physicians Gartman, E., Lahijani, S., Gilson, D. 2006

Footer Links:

Stanford Medicine Resources: